Read by QxMD icon Read


Qin Xiang Ng, Collin Yih Xian Ho, Dongju Shin, Nandini Venkatanarayanan, Hwei Wuen Chan
Background: Travellers' diarrhoea affects tens of millions of people travelling to less developed countries or regions annually. There are positive reports of the use of rifaximin, a non-absorbed, gut-selective antibiotic to prevent travellers' diarrhoea. This study will critically review and analyse clinical trials on the subject. Methods: Using the keywords [diarrhoea OR diarrhoea OR travel*] AND [rifaximin OR xifaxan OR xifaxanta OR normix OR rifagut], a preliminary search on the PubMed and Ovid databases yielded 411 papers published in English between 1 January 1988 and 1 July 2016...
September 1, 2017: Journal of Travel Medicine
Sabesan Karuppiah, Katarzyna Pomianowski
No abstract text is available yet for this article.
February 15, 2017: American Family Physician
(no author information available yet)
No abstract text is available yet for this article.
August 3, 2015: Medical Letter on Drugs and Therapeutics
Lesley J Scott
Oral rifaximin 550 mg (Refero(®); Targaxan(®); Tixteller(®); Xifaxan(®)) twice daily, either alone or more commonly with medicines containing lactulose, is approved in several countries, including the UK, EU and USA, for use in adults with liver disease to reduce the recurrence of episodes of overt hepatic encephalopathy (HE). Rifaximin is a broad-spectrum antibacterial that acts locally in the gut to reduce intestinal flora, including ammonia-producing species, with hyperammonaemia considered to play a central role in the pathogenesis of HE...
December 2014: Drugs
Michael L Misel, Robert G Gish, Heather Patton, Michel Mendler
Hepatic encephalopathy (HE) is a serious but usually reversible neuropsychiatric complication of cirrhosis, inborn errors of metabolism involving disorders of the urea cycle, and noncirrhotic portosystemic shunting that most commonly arises from a transjugular intrahepatic portosystemic shunting procedure. Symptoms can include alterations in cognitive function, neuromuscular activity, and consciousness, as well as sleep disorders and mood changes. HE is associated with significant morbidity and mortality and, if not properly treated, will lead to increased hospital admissions and healthcare costs...
April 2013: Gastroenterology & Hepatology
Jennifer M Belavic
Hepatic encephalopathy (HE) is responsible for an average of 50,000 hospitalizations of approximately 5.5 million individuals with liver cirrhosis every year. HE is a reversible complication of liver failure that causes neuropsychiatric problems. HE patients experience neurologic changes related to cognitive, psychiatric, and motor impairment. This impairment can be accompanied by a number of symptoms including decreased mental status, memory impairment, sensory changes, lack of concentration, disorientation, and coma...
July 2011: Nurse Practitioner
(no author information available yet)
No abstract text is available yet for this article.
November 1, 2010: Medical Letter on Drugs and Therapeutics
Amy J Keenum, M David Stockton
No abstract text is available yet for this article.
December 15, 2005: American Family Physician
(no author information available yet)
No abstract text is available yet for this article.
September 13, 2004: Medical Letter on Drugs and Therapeutics
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"